US FDA approval Orchid's ANDA for Cefpodoxime Proxetil

17 Nov 2007

1

The US FDA has approved the Chennai-based Orchid Chemicals & Pharmaceuticals Ltd abbreviated new drug application (ANDA) for Cefpodoxime Proxetil Tablets.  

The product is available in two dosage strengths, 100 mg and 200 mg.

Cefpodoxime Proxetil is a 3rd generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases.

With limited generic competition in this product, Orchid hopes to acquire a sizeable market share and revenues in the US market.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers